Logo image
Sign in
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease
Journal article   Peer reviewed

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease

M. F. Lew, R. Pahwa, M. Leehey, John M. Bertoni and G. Kricorian
Current Medical Research and Opinion, Vol.23(4), pp.741-750
04/2007
PMID: 17407630

Metrics

3 Record Views

Details